Senior Director, Investments
Kathy Meserve is Director of Investments with Emerging Companies Development at NCBiotech. In this role, Kathy identifies and evaluates early stage NC-based life science companies for loans, then mentors and supports selected companies with strategic planning, follow-on funding and introductions for licensing, co-development partnerships and acquisitions.
Kathy brings over 25 years of experience as a scientist and business executive in the pharmaceutical and biotechnology industry. Prior to joining NCBiotech, as a business development consultant for eight years, Kathy provided European and U.S. pharma, biotech and medtech company clients with market research, business strategy development, introductions to corporate partners and licensors, funding advisory services, scouting, due diligence, marketing support and launch planning to expand their businesses in the U.S. market through corporate partnerships, licensing agreements and U.S. subsidiary establishment. Kathy has been directly responsible for growing several small life sciences companies by serving in various senior business development roles.
As Director of Science & Technology Evaluation at Calvert Research, Kathy scouted for and evaluated early-stage pharmaceutical assets for investment and acquisition. In project management at GSK, Kathy worked with clinical stage programs keeping teams on track for on-time regulatory submissions and also worked on the commercial launch of Advair®. Kathy began her career working for 10 years as a formulation scientist at Genentech and GSK, gaining experience with a broad variety of dosage forms.
Kathy served as chair of the RTP Chapter of the Licensing Executives Society in 2014, has been an invited mentor and judge for the Southeast BIO competition, was co-founder of RTP Advisory Board of the Healthcare Businesswomen’s Association (HBA), and has served as a mentor in the HBA since 2010.
Kathy earned her B.A. in Biology at the University of California at Santa Cruz with coursework focus to support a career in biotechnology. Throughout her career, she has expanded her education with professional courses that include marketing, commercialization, negotiation, project management and finance.